Acadia Pharmaceuticals ACAD shares surged 26.5% on Friday after the company announced that the U.S. District Court in ...

Acadia Pharmaceuticals strengthens Nuplazid's IP, anticipates stabilization in commercial performance, and eyes future ...

ACADIA Pharmaceuticals shares gained 26.5% to close at $22.26 on Friday. These analysts made changes to their price targets ...

Acadia Pharma gets favourable ruling from Delaware District Court in Nuplazid formulation patent litigation: San Diego Monday, May 19, 2025, 17:00 Hrs [IST] Acadia Pharmaceuticals ...

S hares of Aurobindo Pharma rose over 3% on Monday, May 12, following an upgrade from brokerage firm Motilal Oswal, which ...

Acadia Pharmaceuticals ( NASDAQ: ACAD) soared 28% after a court ruling in patent suit regarding its drug Nuplazid, which is ...

A six-month programme, the CLP aims to transform promising professionals into dynamic leaders by equipping them with skills ...

With the stock correcting 12-13% over the past six months, current valuations appear attractive, brokerage firm Motilal Oswal ...

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing ...

Post-Graduation Certification in Leadership program by Aurobindo Pharma & IMT Hyderabad for middle managers' growth." ...

With the stock currently trading at Rs 1141.50, Aurobindo Pharma has experienced a notable decline in today's session.

Aurobindo Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1217. The stock has experienced fluctuations today ...